The 20th annual BIO-Europe Spring is heading to Lisbon, Portugal, from March 23-25, 2026, with a digital experience to follow on March 31-April 1. For the first time, BIO-Europe Spring and LSX Europe ...

Georgia Tech’s vision of an 18-acre innovation district for medical and technology startups is beginning to become a reality. The research university and its development partners held a groundbreaking ...

From at-home microbiome testing to personalised diets and drug discovery ambitions, Bengaluru-based deeptech startup Leucine Rich Bio is shifting healthcare from treatment to prevention.

Bio-Rad is a "picks and shovels" company in the life sciences industry, but lacks standout growth, margins, or returns, and that has been largely true for more than two decades. Recent trends in the ...

SYRACUSE, N.Y. — A Syracuse based bio-science company is getting new funding to help develop their research tool. Triton Bio works to develop safer foods and speed up the development of medicine, a ...

The lineup includes WellNrich Leanepic™, a proprietary botanical extract designed to support muscle health naturally. It has successfully received FDA NDI Notification in July of 2025, demonstrating ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Briefly Bio, a startup based in London, has announced a small but ...

Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. Over 64 years ago, the ocean quacked. Specifically, sailors aboard ...

A rendering of buildings planned for the downtown Research and Development District. Courtesy of IQHQ/Transparent House Premier biotech companies, investors, and industry talent from all over the ...

KENT, Ohio – By the fall of 2027, the Bio-Med Science Academy STEM School will relocate to the Michael Schwartz Center building on Kent State University’s Kent Campus, according to a university news ...

Belite Bio's lead drug, Tinlarebant, targets eye diseases STGD1 and GA, showing promising results but with delayed phase 3 trial data expected by late 2024 or early 2025. Tinlarebant works by reducing ...

For International Day of Women and Girls in Science, we’ve curated a selection of books, films and online communities for women in science ...